8-KAcquisitions & DispositionsExhibits & Filings

Elevance Health, Inc. 8-K Report, Acquisition Completed (Apr 20, 2022)

Filed April 20, 2022For Securities:ELV

Summary

Elevance Health, Inc. (formerly Anthem, Inc.) filed an 8-K on April 20, 2022, to report its first quarter 2022 financial results. The filing primarily references a press release (Exhibit 99.1) detailing these results. While the specific financial figures are not embedded within the 8-K itself, this report serves as the official notification of the company's performance during the period ended March 31, 2022. Investors should note that this 8-K is a procedural filing to furnish the earnings release. The forward-looking statements section highlights the inherent risks and uncertainties in the company's business, including the impact of public health emergencies like COVID-19, healthcare cost trends, regulatory changes (including the Affordable Care Act), economic conditions, and competitive pressures. The company also flags risks related to its PBM business, cybersecurity, government program compliance (Medicare/Medicaid), and potential M&A activities.

Key Highlights

  • 1Filing of an 8-K on April 20, 2022, to report first quarter 2022 financial results.
  • 2The primary content of the report is a press release (Exhibit 99.1) detailing financial performance for the quarter ended March 31, 2022.
  • 3This filing is a formal notification of the company's results, with detailed figures expected in the accompanying press release.
  • 4The report includes a comprehensive 'Forward-Looking Statements' section outlining potential risks and uncertainties.
  • 5Key risks mentioned include the impact of pandemics (like COVID-19), healthcare cost inflation, regulatory environments (ACA, Medicare/Medicaid), and PBM business operations.
  • 6Cybersecurity threats and potential M&A activities are also identified as areas of risk.
  • 7The company cautions investors against undue reliance on forward-looking statements due to the inherent unpredictability of future events.

Frequently Asked Questions

The main purpose of this 8-K filing is to officially report Elevance Health's financial results for the first quarter ended March 31, 2022, by furnishing the accompanying press release.

The specific financial results are detailed in the press release furnished as Exhibit 99.1 to this 8-K filing. Investors should refer to that document for detailed financial figures and performance metrics.

The filing highlights significant risks including the ongoing impact of public health emergencies (e.g., COVID-19), trends in healthcare costs and utilization, evolving healthcare regulations (such as the ACA and Medicare/Medicaid), economic conditions, competitive pressures, cybersecurity breaches, and risks associated with its Pharmacy Benefit Management (PBM) business.

This 8-K filing itself does not provide updated financial guidance. It primarily reports on past performance for the first quarter of 2022. Any forward-looking financial projections or guidance would be contained within the furnished press release (Exhibit 99.1).